Kyle Serikawa

Seattle resident since 1996. Kyle has been working in the biopharma industry for almost twenty years, working to develop therapeutics and diagnostics to positively impact human health. In his current role, Kyle manages a program in collaboration with Microsoft to use Artificial Intelligence and Machine Learning techniques to understand the complexity of the immune system.